Related references
Note: Only part of the references are listed.Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy
Chuanli Ren et al.
CANCER BIOLOGY & THERAPY (2011)
Circulating Tumors Cells as Biomarkers Progress Toward Biomarker Qualification
Daniel C. Danila et al.
CANCER JOURNAL (2011)
Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials
Lot A. Devriese et al.
CANCER TREATMENT REVIEWS (2011)
HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis
S. J. MARTIN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis
Elisabetta Rossi et al.
CLINICAL CANCER RESEARCH (2010)
Circulating tumor cells: utility for predicting response to anti-EGFR therapies?
Marielena Mata et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial
Elyse E. Lower et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2009)
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
A. Kalikaki et al.
BRITISH JOURNAL OF CANCER (2008)
Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients
Cesar Sze-Chuen Wong et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: Impact on patient management
Valentina Guarneri et al.
ONCOLOGIST (2008)
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2008)
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2007)
Case study of the morphologic variation of circulating tumor cells
Dena Marrinucci et al.
HUMAN PATHOLOGY (2007)
Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations
S Chow et al.
CYTOMETRY PART A (2005)
Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications
PO Krutzik et al.
CLINICAL IMMUNOLOGY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events
PO Krutzik et al.
CYTOMETRY PART A (2003)
Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications
M Pallis et al.
LEUKEMIA RESEARCH (2003)
Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity
JW Jacobberger et al.
CYTOMETRY PART A (2003)
Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors
S Chow et al.
CYTOMETRY (2001)